La Caixa Foundation concedes 35 fellowships for early-stage researchers of any nationality to pursue their PhD studies in the best Spanish and Portuguese research centres and units with excellence distinction: Spanish Seal of Excellence Severo Ochoa, María de Maeztu or Health Institute Carlos III and Portuguese units accredited as “excellent” by the Fundação de Ciência e Tecnologia. This program is only addressed to PhD research projects on STEM disciplines: life sciences and health, experimental sciences, physics, chemistry and mathematics. In order to do the research in Spain, candidates must have resided or carried out their main activity in Spain for less than 12 months in the last 3 years. More information can be found here.
Aspirants must present their candidacy before January 27th, 2022, and the projects are meant to start on Fall Term 2022.
Selected candidates will choose between a list of specific projects, available here.
IDIBELL offers 10 spots for incoming INPhINIT awardees:
Characterization and potentiation of motor, cognitive and emotional brain cortico-striatal circuits in people with Huntington’s disease diagnosis using an MRI neuroimaging approach
Dr. Estela Càmara Mancha – Diffusion MRI Brain Connectivity group
Development of next-generation stem cell-derived organoids using engineering strategies
Dr. Antonella Consiglio – Stem Cells and Neurodegeneration Laboratory
Translational Medicine Area
Development of crispr-cas technologies and modelling of human mutations in Caernorhabditis elegans
Dr. Julián Cerón Madrigal – Modeling human diseases in C. Elegans
Novel immunomodulatory and inflammation-resolver biologics against autoimmune diseases
Dr. Josep M. Aran – Immune-inflammatory Processes and Gene Therapy
Predoctoral Clinical Researcher for the Infectious Diseases-Infection Control group
Dr. Mireia Puig-Asensio – Epidemiology of bacterial infections. Research on pathogenesis and molecular basis of antimicrobial resistance
Exploring novel oncologic targets hidden in the non-coding genome
Dr. Sonia-Vanina Forcales Fernández – Chromatin dynamics in cancer and cell fate
Food bioactive compounds and prostate cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Scientific bases for future dietary recommendations.
Dr. Raul Zamora Ros – Nutrition and Cancer
New therapeutic strategies for malignant pleural mesothelioma
Dr. Ernest Nadal – Preclinical and experimental research in thoracic tumors
Towards a precision medicine using TGF-β inhibitors in hepatocellular carcinoma and cholangiocarcinoma
Dr. Isabel Fabregat – TGF-beta and Cancer
Regenerative Medicine Area
Characterization of post-transcriptional regulatory networks and their function in stablishing cell identity
Dr. Mireya Plass – Gene regulation of cell identity